SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021848
Filing Date
2022-11-03
Accepted
2022-11-03 16:07:20
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-20220930.htm   iXBRL 10-Q 2889674
2 EX-31.1 sndx-ex31_1.htm EX-31.1 17797
3 EX-31.2 sndx-ex31_2.htm EX-31.2 18207
4 EX-32.1 sndx-ex32_1.htm EX-32.1 18441
  Complete submission text file 0000950170-22-021848.txt   10726277

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sndx-20220930_lab.xml EX-101.LAB 396403
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sndx-20220930_pre.xml EX-101.PRE 295130
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sndx-20220930_def.xml EX-101.DEF 189096
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sndx-20220930.xsd EX-101.SCH 51525
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sndx-20220930_cal.xml EX-101.CAL 45066
57 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20220930_htm.xml XML 2621617
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 221357970
SIC: 2834 Pharmaceutical Preparations